Loading...
NPI 1194261594 · Juneau, AK · Federally Qualified Health Center (FQHC)
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Southeast Alaska Regional Health Consortium is a federally qualified health center (fqhc) provider located in Juneau, Alaska. This profile covers 0 Medicare and 35 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Southeast Alaska Regional Health Consortium |
| Address | 225 Front Street |
| City | Juneau |
| State | AK |
| ZIP | 99801 |
| Taxonomy | Federally Qualified Health Center (FQHC) |
| NPI Enumerated | January 10, 2017 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $19.9M |
| Medicare | $0 |
SOUTHEAST ALASKA REGIONAL HEALTH CONSORTIUM is effectively single-payer in the available dataset: there is no Medicare billing on file while total Medicaid revenue is $19.9M. The absence of any Medicare revenue suggests this entity’s Medicaid work is the primary source of billed clinical activity and reimbursement in the captured period.
Revenue is highly concentrated: the top three Medicaid codes (H0020, 99214, 99213) together account for 93.6% of this provider’s total Medicaid revenue. In particular, H0020 alone generates $15.2M (76.2% of Medicaid revenue), making methadone administration the dominant revenue driver for the organization.
The code mix indicates a service-line focus on substance use disorder treatment and related behavioral health care: H0020 (methadone administration) has 20.8K claims at $729 avg paid/claim and $15.2M revenue, and supporting behavioral-health codes such as H2021, T1007, H0001, and H0002 appear elsewhere on the ledger. This pattern—combined with the FQHC taxonomy—suggests the consortium operates as a Federally Qualified Health Center with a significant clinic-level emphasis on opioid use disorder treatment and wrap-around behavioral health services.
Despite the large dollar share from H0020, the provider’s in-state competitive standing on that specific code is not dominant: H0020 ranks #5 of 8 providers in-state (43th percentile; typical, unremarkable volume for this code). Similarly, 99214 (3.1K claims, $695 avg paid/claim, $2.1M revenue) ranks #85 of 440 providers in-state (81th percentile; typical, unremarkable volume for this code) and 99213 (2.2K claims, $603 avg paid/claim, $1.3M revenue) ranks #143 of 485 (71th percentile; typical, unremarkable volume). These rankings indicate meaningful participation in established-patient E/M visits statewide but not clear dominance.
Operational footprint appears clinical and programmatic rather than procedural: G0467 (FQHC visit) shows 371 claims at $39 avg paid/claim for $14.5K (0.1% of Medicaid revenue), reflecting that bundled/chronic FQHC visit revenue is a very small share compared with substance-use treatment billing. Ancillary services such as presumptive drug testing (80305: 1.9K claims, $91 avg paid/claim, $168.5K revenue) and definitive testing (80306: 77 claims, $475 avg paid/claim, $36.6K revenue) exist but account for modest Medicaid revenue.
Several procedure codes have claims reported but show $0 avg paid/claim and $0 revenue in the dataset (for example G0483, 86580, 91301, 93268), indicating claims were submitted for these services without recorded Medicaid payments in the available files. This pattern is limited to a small share of overall activity but is notable when interpreting billed services versus paid Medicaid revenue.
Tenure and enrollment data show the NPIs were enumerated on 2017-01-10 (~9 years ago), establishing a multi-year presence in the state; the organization has had time to scale its methadone/substance-use operations given the heavy revenue concentration on H0020. The combination of several behavioral-health codes and case management codes (T1016, T1007, T1016) aligns with an integrated behavioral-health service model within the FQHC structure.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
35 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 20,790 | $730 | $15.2M |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 3,050 | $700 | $2.1M |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 2,220 | $600 | $1.3M |
| H2021 | Community-based wrap-around services, per 15 minutes | 710 | $750 | $528.2K |
| 80305 | The lab analyst performs presumptive drug test(s) by any method that the analyst can read by direct optical observation only, without instrument assistance, to screen for any number of drug classes… | 1,850 | $90 | $168.5K |
| T1016 | Case management, each 15 minutes | 360 | $430 | $155.8K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 120 | $520 | $63.7K |
| T1007 | Alcohol and/or substance abuse services, treatment plan development and/or modification | 140 | $440 | $59.2K |
| 0011A | N/A | 60 | $740 | $45.3K |
| 99442 | N/A | 120 | $370 | $44K |
Showing 1–10 of 35
How this provider's Medicaid billing volume and revenue compare to other Alaska providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Alaska median
35 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 5 | 10 | 36,340 | $80 | $10.5M |
| H2021 | Community-based wrap-around services, per 15 minutes | 45 | 80 | 1,070 | $330 | $1.3M |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 60 | 100 | 360 | $340 | $1.2M |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 143 | 490 | 680 | $260 | $1M |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 55 | 70 | 570 | $110 | $829.4K |
| T1016 | Case management, each 15 minutes | 61 | 90 | 1,620 | $150 | $606.4K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 3 | 10 | 490 | $470 | $509K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 85 | 440 | 580 | $170 | $458.7K |
| 87522 | A lab tests a patient’s specimen to measure the amount of hepatitis C virus present. This may be referred to as viral load. | 6 | 10 | 360 | $350 | $280.6K |
| 86580 | The lab analyst performs an intradermal skin test on a patient to test for tuberculosis. | 12 | 20 | 130 | $430 | $277.4K |
Showing 1–10 of 35
Other providers in the same ZIP code as Southeast Alaska Regional Health Consortium, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.